Macquarie upgrades its forecasts, based on GNC's update. Now forecasting:
FY2022
Revenue: $6.02b
EBITDA: $519m
NPAT: $268m ($1.19/share)
Dividend: 27cps
FY2023
Revenue: $4.75b
EBITDA: $295m
NPAT: $117m (53c/share)
Dividend: 26cps
Its valuation and 12-month target price is $9.48.
I think Macquarie's dividend forecasts are light given expected npat, but they might be expecting ongoing share buybacks (remember that a $50m buy back is to commence this month ...).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.55 |
Change
-0.030(0.40%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $7.57 | $7.58 | $7.53 | $21.27M | 2.816M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5814 | $7.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.59 | 15758 | 3 |
View Market Depth
| Last trade - 16.11pm 30/07/2025 (20 minute delay) ? |
| GNC (ASX) Chart |